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Abstract The role of intensive glycaemic control in preventing
microvascular disease in diabetes is well established. Iatrogenic
hypoglycaemia is, however, a major barrier to effective treat-
ment. Hypoglycaemia is associated with a significant level of
morbidity and, despite pharmacological and technological ther-
apeutic advances, reported rates of severe hypoglycaemia in
clinical practice have not fallen over the last 20 years. This
suggests that human factors are of major relevance and that
ensuring the effective self-management of diabetes is an impor-
tant strategy for the reduction of hypoglycaemic risk. Most of
the evidence for the impact of this strategy on hypoglycaemia
risk is confined to adults with type 1 diabetes although, in this
review, we also cite studies that have specifically addressed this
in type 2 diabetes. There are relatively few adequately powered
RCTs that have rigorously evaluated the effectiveness of struc-
tured education and training programmes on hypoglycaemia;
however, the available data suggest a subsequent reduction in
severe hypoglycaemia rates of around 50%, a rate reduction
that is comparable with that observed following technological
interventions. Furthermore, longitudinal observational cohorts
support these data, showing similar reductions in rates of
hypoglycaemia following structured education. Those who
continue to experience recurrent hypoglycaemia and impaired
awareness of hypoglycaemia despite education and training in
diabetes self-management may benefit from technological in-
terventions and/or interventions that specifically address psy-
chological factors that contribute to hypoglycaemia risk; how-
ever, there is urgent need for further research in this area. In the
meantime, structured education for effective self-management
of diabetes should be part of routine therapy for all those with
type 1 diabetes.
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Abbreviations
BGAT Blood Glucose Awareness Training
CGM Continuous glucose monitoring
CSII Continuous subcutaneous insulin infusion
DAFNE Dose Adjustment for Normal Eating
DAFNE-HART DAFNE-Hypoglycaemia Awareness
Restoration Training
DTTP Diabetes Treatment and Teaching
programme
HAATT Hypoglycemia Anticipation, Awareness
and Treatment Training
HypoCOMPaSS Recovery of Hypoglycemia Awareness in
Long-Standing Type 1 Diabetes
IAH Impaired awareness of hypoglycaemia
SMBG Self-monitoring of blood glucose
TIM Tayside insulin management
Introduction
The importance of intensive glycaemic control in preventing
complications in both type 1 and type 2 diabetes is well
established [1, 2]. However, these early studies also
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demonstrate that intensive glucose control increases the risk of
severe hypoglycaemia [1, 2], although recent clinical trials
suggest that the overall risk of severe hypoglycaemia is now
falling substantially using current glucose-management strat-
egies [3, 4]. This is in marked contrast with observational
studies [5–7] that show that severe hypoglycaemia rates re-
main comparable with those reported over 20 years ago [8],
despite the introduction of insulin analogues, continuous sub-
cutaneous insulin infusion (CSII) and continuous glucose
monitoring (CGM). These observations indicate that addition-
al factors contribute to the risk of hypoglycaemia in clinical
practice. In this review, we argue that effective self-
management is the key to reaching glucose targets while
minimising the risk of hypoglycaemia.
Here, we will first briefly consider the definition and epi-
demiology of hypoglycaemia in diabetes. As a disease, type 1
diabetes is arguably unique, given the relentless demand it
places on an individual to self-manage their condition. Since
education and training are likely to be critical for acquiring
self-management skills, we will focus on the role of structured
education/training in the clinical management of type 1 dia-
betes. In referring to structured education, we cite literature
where a fixed curriculum has been used by trained educators
to teach individuals to self-manage their diabetes more effec-
tively. When describing the various methods used to evaluate
the effects of the education/training programmes on
hypoglycaemia, we highlight important differences that we
consider to be relevant. Psychological factors are equally im-
portant in determining a person’s ability to effectively self-
manage their condition and while a detailed review of studies
addressing these factors is beyond the scope of this review,
inevitably, high-quality structured education addresses some
psychological factors, at least in part.
For this review, we searched PubMed (MEDLINE) and
EMBASE, from inception (1964 and 1974, respectively) until
1 October 2016, using these keywords and synonyms in ad-
dition to ‘self’ and ‘management’ and ‘self-management’:
‘hypoglycaemia’; ‘low glucose’; ‘hypoglycaemia avoidance’,
‘structured’ and ‘education’; ‘structured-education’, ‘insulin’
and ‘training’; ‘insulin-training’; ‘carbohydrate’ and
‘counting’; ‘carbohydrate-counting’. We additionally used a
recently published systematic review and meta-analysis [9] to
reconcile studies on type 1 diabetes that were not identified in
our original search.
Epidemiology of hypoglycaemia
An ADA working group [10] defined symptomatic
hypoglycaemia as the presence of typical symptoms of
hypoglycaemia with a glucose measurement <3.9 mmol/l
and severe hypoglycaemia as any episode requiring the assis-
tance of another person to recover. These definitions have
limitations, however, and universal application is difficult.
For example, paediatricians generally include hypoglycaemic
episodes that cause coma or seizures in their definition for
severe hypoglycaemia (since young children always need ex-
ternal assistance). Furthermore, many studies report
hypoglycaemic episodes at a glucose level lower than
3.9 mmol/l, often on the basis that they are more clinically
relevant. This inconsistency in hypoglycaemia classification
makes it difficult to compare different studies and interven-
tions. In particular, episodes of hypoglycaemia that may lead
to impaired awareness of hypoglycaemia (IAH) or that are
associated with mortality are not recorded systematically ac-
cording to an agreed classification.
Recently, the ADA and the EASD agreed a position state-
ment that proposes the inclusion of a third glucose level,
denoting ‘clinically important’ (in addition to <3.9 mmol/l
and severe hypoglycaemia) at <3.0 mmol/l for the classifica-
tion of hypoglycaemia [11]. If this classification was univer-
sally adopted for use in clinical trials, it could enable reliable
comparisons of the effectiveness of educational or therapeutic
interventions for the reduction of hypoglycaemia rates in dia-
betes. However, the new proposed criteria for hypoglycaemia
set by the ADA/EASD have yet to be agreed more widely.
Thus, in this review we will generally confine our comments
to severe hypoglycaemia in adults, the definition of which
(severe hypoglycaemia: requiring assistance of another person
to recover) is currently widely accepted.
Studies of severe hypoglycaemia in adults
with diabetes
Most studies reporting severe episodes of hypoglycaemia in
diabetes are associated with several limitations. First, the data
are generally compiled from patient-reported episodes and
since retrospective studies rely on an individual’s recall of
events, they are susceptible to recall bias. Somewhat arbitrari-
ly, the frequency of non-severe hypoglycaemic episodes is
considered reliable if the data are collected retrospectively at
monthly intervals, while severe episodes are thought to be
accurately identified for up to 1 year later. Episodes collected
prospectively are likely to be more reliable in ascertaining the
true frequency and predictors of hypoglycaemia, although,
since data are collected over relatively brief periods
(4–12 weeks) and then extrapolated to establish annual inci-
dence, this may introduce sampling error. Second, studies that
seek recruits by advertising may exhibit selection bias since
individuals with diabetes with hypoglycaemic problems are
arguably more likely to participate. Few studies are truly pop-
ulation based because of the challenge of identifying all indi-
viduals with diabetes. Third, rates of hypoglycaemia among
people with diabetes are not normally distributed, with many
individuals reporting no events and a few experiencing a high
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number of events; statistical analyses can adjust for this but are
not always applied. Fourth, the reporting of hypoglycaemia is
particularly unreliable in elderly individuals, in whom the
symptomology of hypoglycaemia is different from that in
younger people. In elderly people, episodes of hypoglycaemia
(even those that are severe) may be attributed to cerebrovas-
cular events [12]. Finally, many studies recruit relatively small
numbers and are therefore underpowered to compare the ef-
fects of therapeutic interventions (including educational inter-
ventions) on rates of severe hypoglycaemia.
One of the most reliable assessments of hypoglycaemic
burden has emerged from a true population-based prospective
study. In this study, the annual incidence of severe
hypoglycaemia episodes in insulin-treated type 2 diabetes
was observed to be less than half of that in type 1 diabetes
(1.15 events per person per year in type 1 diabetes vs 0.35
events per person per year in type 2 diabetes) [13]. In both
type 1 and type 2 diabetes, less than 10% of the study popu-
lation had a mean HbA1c <7% (53 mmol/mol) and HbA1c was
not a significant predictor of prospective hypoglycaemia
(p = 0.248 and p = 0.099 for type 1 and type 2 diabetes,
respectively).
The prevalence of IAH is estimated to be 50% in those with
type 1 diabetes after 25 years or more of treatment [14–16]. In
insulin-treated type 2 diabetes, in one observational study, the
prevalence of IAH was reported to be ~10%, although confir-
matory data are lacking [17]. Duration of treatment with insu-
lin is a key predictor of the risk of hypoglycaemia, with rates
of severe episodes rising in both type 1 and type 2 diabetes
with longer treatment duration [5]. Interestingly,
hypoglycaemia risk in type 1 and type 2 diabetes was compa-
rable in one study in which participants were matched for
duration of treatment with insulin [18]. A global rise in the
incidence of type 2 diabetes [19] coupled with improved ac-
cess to insulin treatment and longer life expectancies means
that the management of hypoglycaemia in type 2 diabetes is
becoming increasingly important. In numerical terms, at least,
the burden of hypoglycaemia as a clinical problem is already
greater in type 2 diabetes than in type 1 diabetes.
Structured education programmes in the clinical
management of hypoglycaemia
Programmes aimed at reversing IAH and reducing the risk
of severe hypoglycaemia are based on the premise that re-
duced neuroendocrine and symptomatic responses to
hypoglycaemia, even in long-standing IAH, can be reversed
with meticulous avoidance of further hypoglycaemia [20, 21].
However, the potential for structured education/training to
reduce hypoglycaemia emerged many years before the re-
search that first identified the contribution of antecedent
hypoglycaemia to reduced awareness [22, 23].
The Diabetes Teaching and Treatment programme
In Düsseldorf, Germany, Muhlhauser and colleagues
recognised the opportunity that the introduction of self-
monitoring of blood glucose (SMBG) presented in improving
management of type 1 diabetes. The fundamental principles of
the Diabetes Teaching and Treatment programme (DTTP) in-
cluded separating basal and pre-meal bolus insulin, intensive
SMBG (including nocturnal testing), counting carbohydrates
to permit a flexible diet that is comparable with that of people
without diabetes, and a structured written curriculum deliv-
ered by trained educators. The course was delivered over
5 days to inpatients in groups of six to eight.
The DTTPwas evaluated in a series of clinical trials conduct-
ed in countries behind the Iron Curtain, since the authors con-
sidered that the spreading influence of the DTTP programme
had ‘contaminated’ German diabetes centres. Having
established that the course resulted in markedly improved
HbA1c and fewer hospital admissions [24], the authors went
on to conduct a large controlled trial in 300 participants [25].
Outcomes in those undertaking the course were compared at 24
month follow-up with a waiting-list control group and also with
a control group taught basic information. Participants were
taught to calculate insulin doses based on the carbohydrate value
of different meals, while keeping blood glucose within tight
targets. The course resulted in a long-term improvement in
glycaemic control (HbA1c was improved by 1.5% at 1 year
follow-up compared with control participants taught basic infor-
mation alone), which was accompanied by a marked reduction
in ketoacidosis, although hypoglycaemia rates were unchanged.
In another DTTP trial, Starostina et al [26] reported that mean
HbA1c was reduced by 3% in the intervention group compared
with the control group at 1 year of follow-up, again with no
reported difference in rates of severe hypoglycaemia. These
studies, though promising, are limited by being underpowered
to demonstrate differences in rates of severe hypoglycaemia.
A large observational study from the same group [27] pre-
sented findings from a 6 year follow-up in a cohort of indi-
viduals with type 1 diabetes who had undergone the DTTP.
They reported a reduction in HbA1c of 0.7%, while the inci-
dence of severe hypoglycaemia had fallen from 0.28 episodes
per person per year in the year before DTTP to 0.17 episodes
per person per year at follow-up (p < 0.05). Furthermore,
another observational study demonstrated that the exponential
relationship between the level of HbA1c and the risk of severe
hypoglycaemia (which was clearly present before participa-
tion in the course) could be abolished 12 months following
inpatient DTTP training (Fig. 1) [28]. Although observational
studies provide a weaker level of evidence compared with
clinical trials, the large number of participants and the long
period of follow-up strongly suggest that participation in the
DTTP improves HbA1c while reducing severe hypoglycaemia
by approximately 50% [28, 29].
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DTTP-based programmes: ‘dose adjustment for
normal eating’ and ‘Tayside insulin management’
The reported success of these programmes has led to their adop-
tion across a range of countries. In the UK, a multicentre RCT
measured the impact of a structured education course (Dose
Adjustment for Normal Eating [DAFNE]), modelled on the
DTTP, on glycaemic control and quality of life in type 1 diabetes
[30]. At three UK centres, 169 individuals withmoderate-to-poor
glycaemic control (HbA1c 7.5–12% [58.5–107.7 mmol/mol])
participated in a 5 day structured education outpatient pro-
gramme taught by two educators (diabetes specialist nurses and
dietitians). Participants were randomised either to attend the
DAFNEcourse immediately or to receive usual care for 6months
prior to attending the course, thus acting as a waiting-list control
group. There were modest improvements in HbA1c (0.7–1% at
6 months; p < 0.0001), whilst no change was observed in the
control group. However, there was not a significant reduction in
the incidence of severe hypoglycaemia, perhaps because the trial
was underpowered to detect a difference.
Importantly, longer-term observational studies involving
larger numbers of participants have demonstrated reductions
in the incidence of severe hypoglycaemia that are comparable
with those seen in the original DTTP studies from Germany,
albeit at higher HbA1c levels. These studies report reductions
in HbA1c (mean difference pre- and post-DAFNE: 0.27%;
p < 0.001) and around a 50% reduction in rates of severe
hypoglycaemia (mean ± SD: pre-DAFNE 1.7 ± 8.5 vs post-
DAFNE 0.6 ± 3.7 episodes per person per year; p < 0.05),
together with improved awareness of hypoglycaemia in up to
43% of participants at 1 year follow-up [31]. The overall rate
of IAH fell from 39.9% to 33%, with reductions in psycho-
logical distress and improvedwellbeing up to 1 year following
programme attendance [31].
Similarly, observational data from a study of the Tayside
insulin management (TIM) structured education programme
showed a reduction in HbA1c (mean 0.4%; p < 0.001) follow-
ing 6 months of participation, a reduction in the annual inci-
dence of severe hypoglycaemia requiring parenteral treatment
and improved awareness of hypoglycaemia in 25% of partic-
ipants [32].
Of note, in both the DAFNE and TIM study, IAH was not
confirmed using an objective measure (such as the Gold
score). However, the DAFNE authors did establish a robust
definition for IAH in the form of a hypoglycaemia awareness
rating that may be less subjective than the Gold score [31, 33].
Programmes focussing on improving hypoglycaemia
awareness
The Recovery of Hypoglycemia Awareness in Long-
Standing Type 1 Diabetes (HypoCOMPaSS) The
HypoCOMPaSS trial seems to suggest that even a brief edu-
cational intervention focussed on hypoglycaemia detection in
type 1 diabetes can produce a significant improvement in the
rate of moderate and severe hypoglycaemia without
compromising metabolic control [34]. The trial involved 96
adults with type 1 diabetes and IAH, randomised in a 2 × 2
factorial design to CGM, insulin pumps or multiple daily in-
jections alone. All participants received a brief half-day educa-
tion programme focussing on reducing episodes of
hypoglycaemia. At 6 months, IAH had improved in all groups
and rates of severe hypoglycaemia fell from 77% of individ-
uals in the 6 months before the trial to 20% during the 6 month
trial (pre-HypoCOMPaSS 8.9 ± 13.4 vs post-HypoCOMPaSS
0.8 ± 1.8 episodes per person per year; p = 0.0001) without
deterioration in HbA1c (pre-HypoCOMPaSS 8.2%
[66.1 mmol/mol] vs post-HypoCOMPaSS 8.1% [65 mmol/
mol]) [34]. Importantly, neither pumps nor CGM (or a combi-
nation of both) produced any major additional positive effect
compared with education and ongoing support alone. Since all
three arms of this study were delivered in participating sites,
there is a possibility of ‘contamination’ between findings.
Furthermore, it was not possible to ascertain whether the ben-
efit was due to the half-day education or the weekly support
provided by the research fellows. Since it seems unlikely that
brief education alone would have caused this degree of behav-
iour change, it is probable that both components contributed to
these outcomes.
The Blood Glucose Awareness Training programme Not
all individuals respond to structured education and continue to
experience IAH and recurrent hypoglycaemia. Some have
psychological and cognitive barriers that interfere with their
ability to avoid hypoglycaemia [35]. A number of interven-
tions have been developed specifically to address the
S
ev
er
e 
hy
po
gl
yc
ae
m
ia
(e
ve
nt
s 
pe
r 
pe
rs
on
-y
ea
r)
 
HbA1c (%)
0.6
0.5
0.4
0.3
0.2
0.1
0
5 6 7 8 9 10 11 12 13
Fig. 1 Evaluation of the efficacy of teaching flexible, intensive insulin
therapy as part of a structured training course on glycaemic control and
severe hypoglycaemia rates in 9583 individuals with type 1 diabetes
between 1992 and 2004. Participants underwent 20 h of training as inpa-
tients and were advised to measure blood glucose before main meals and
at bedtime. Insulin was adjusted to actual blood glucose level and
intended carbohydrate intake. Red circles, 1 year prior to intervention;
green triangles, 1 year after intervention [28]. To convert values for
HbA1c in DCCT % into mmol/mol, subtract 2.15 and multiply by
10.929. Adapted from [28] with permission of Springer-Verlag
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problems associated with IAH. However, not all of these in-
terventions are available for individuals who have previously
participated in structured education. The interventions are of-
ten described as ‘psycho-behavioural’ but, although some are
delivered by psychologists, the psychological theory onwhich
they are based is not always described in detail. Some include
elements of structured education while others focus on other
aspects of self-management. In the absence of detailed de-
scriptions of the development of these interventions in the
published literature, we have found it difficult to identify
any common features of these programmes. However, Blood
Glucose Awareness Training (BGAT) provides an example of
how psychological intervention may be included in an educa-
tion programme to improve hypoglycaemia awareness.
The BGAT programme uses skills-based training to help
participants to detect both hypoglycaemia and hyperglycaemia
over an 8 week period [36]. In BGAT, individuals are taught to
focus on enhanced awareness of internal cues including phys-
ical symptoms (such as motor performance), cognitive skills
(such as difficulty in concentrating) and mood changes.
Participants in BGAT programmes are taught to use these sig-
nals to identify subtle variations in blood glucose. They are also
taught to recognise external cues, including timing and dose of
previous insulin, food consumption and physical exercise, to
anticipate changes in blood glucose. The programme appears to
recruit some individuals with no previous experience of struc-
tured education. A trained psychologist assesses progress and
provides maintenance strategies. In both outpatient [37] and
inpatient [38] settings, BGAT has successfully promoted im-
proved detection of hypoglycaemia in those with IAH and
fewer low glucose readings in those with awareness of
hypoglycaemia, without deteriorating glycaemic control.
A limitation of BGAT studies [36, 39] is baseline rates of
severe hypoglycaemia before intervention were not reported.
Moreover, in the study by Kinsley et al [36], participants that
had experienced an episode of severe hypoglycaemia in the pre-
ceding 2 years prior to the study were excluded, providing a
potential selection bias. Conversely, in a Swiss study using
BGAT principles, those with recurrent severe hypoglycaemia
were specifically encouraged to participate and a demonstrable
decline in severe hypoglycaemia rates (nearly 90%) in the edu-
cation arm was observed [40]. Kinsley et al measured counter-
regulatory responses to hypoglycaemia, which were improved in
those randomised to BGAT compared with control participants.
This study also showed an improvement in glycaemic control,
which was not observed in the Swiss BGAT trial [36, 40].
The Hypoglycemia Anticipation, Awareness and
Treatment Training programme Like BGAT, studies into
Hypoglycemia Anticipation, Awareness and Treatment
Training (HAATT) have demonstrated that structured educa-
tion concentrating on hypoglycaemia detection in type 1 dia-
betes can reduce rates of moderate hypoglycaemia and severe
hypoglycaemia (pre-HAATT 2.0 vs post HAATT 0.4 episodes
per person per year; p < 0.05) without compromising meta-
bolic control (pre-HAATT HbA1c 8.1% [65 mmol/mol] vs
post-HAATT 8.0% [63.9 mmol/mol]) [41]. The psychological
element of HAATT focussed on devising individual plans for
maintaining HAATT principles following the course.
HyPOS A structured education programme developed by
Hermanns and colleagues in Germany [42] involves five
90 min sessions delivered to groups of individuals with IAH
over 5 weeks. This intervention, known as HyPOS, differed
from other studies by exclusively focussing on hypoglycaemia
as opposed to broader principles of diabetes self-management.
When compared with a control group (who received standard
group education) at 6 months, awareness of hypoglycaemia
had improved in the intervention group, although rates of se-
vere hypoglycaemia were not different. Interestingly, when 140
of the original 164 participants were evaluated at 31 months,
rates of severe hypoglycaemia in the intervention group were
around half of those in the control group (mean ± SD: 0.1 ± 0.2
vs 0.2 ± 0.4 episodes per person per year; p = 0.04) [43] .
However, loss to follow-up was not reported and, for reasons
which were unclear, rates of severe hypoglycaemia in both
arms had fallen by fourfold compared with baseline.
DAFNE-Hypoglycaemia Awareness Restoration Training
The DAFNE-Hypoglycaemia Awareness Restoration Training
(DAFNE-HART) pilot study is a psychoeducational interven-
tion aimed for individuals who experience IAH following
DAFNE training [44]. The DAFNE-HART study recruited 24
people with type 1 diabetes that had IAH assessed clinically as
a Gold score ≥ 4. Participants were encouraged to seek
hypoglycaemia cues and consider consequences of
hypoglycaemia and IAH using motivational interviewing and
cognitive behavioural therapy techniques, delivered over
6 weeks by DAFNE educators trained by a clinical psycholo-
gist. In the pilot trial, the investigators reported a significant
reduction in the incidence of severe hypoglycaemia (median
[range]: pre-DAFNE-HART three [0–104] vs post-DAFNE-
HART no [0–3] episodes per person per year; p < 0.001), as
well as improved awareness of hypoglycaemia. HbA1c was
unchanged (pre-DAFNE-HART 7.8% [62 mmol/mol] vs
post-DAFNE-HART 7.8% [61.8 mmol/mol]) 12 months post
intervention [44].
The DAFNE-HARTstudy was an uncontrolled small-scale
pilot study. However, it appears to be the first intervention to
recruit individuals with previous experience of structured ed-
ucation but who continued to have problems with
hypoglycaemia. The study suggests that targeting unhelpful
cognitions and beliefs may be particularly effective in some
individuals although this needs to be confirmed by an ade-
quately powered RCT.
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Comparison of programmes to improve hypoglycaemia
awareness A recent systematic review and meta-analysis
examining interventions that restore awareness of
hypoglycaemia in type 1 diabetes identified 27 studies that
used structured education as the primary intervention [9]. Of
these, only six studies were RCTs (Table 1) and the number
of individuals enrolled was generally less than 200 in each;
the remaining studies were retrospective and observational.
Of these clinical trials, three studies recruited individuals
who had type 1 diabetes and had IAH [41–43], while the
other four recruited unselected individuals [36, 39, 40, 45].
When comparing head-to-head educational programmes that
incorporate a psychological approach vs those that focus
primarily on structured education of insulin therapy, no sig-
nificant difference in severe hypoglycaemia has been ob-
served [9]. However, the relatively few adequately powered
RCTs in this area makes it difficult to establish the benefit of
structured educational interventions. Furthermore, it is clear-
ly impossible to blind clinical trials of a behavioural inter-
vention although recording rates of severe hypoglycaemia (if
reported accurately) and awareness scores are reasonably
objective.
Summary of findings In summary, evidence from trial data
suggests that structured education reduces the incidence of
severe hypoglycaemia and improves awareness of
hypoglycaemia in those with IAH in type 1 diabetes.
Longer-term observational follow-up indicates a reduction in
the rate of severe hypoglycaemia of around 50% following
educational interventions. This is comparable with the reduc-
tion seen with technological interventions including CSII, al-
though one recent trial involving insulin suspend pumps has
reported larger reductions in severe hypoglycaemia rates [46].
Another recent RCT studying those with type 1 diabetes and
IAH reported that CGM reduced severe hypoglycaemia rates
by approximately 40% vs SMBG [47]. The authors controlled
for education by re-training participants in both arms on dia-
betes management prior to randomisation.
High-quality RCTs investigating the role of structured ed-
ucation in those with insulin-treated type 2 diabetes are gen-
erally lacking and even fewer have reported rates of severe
hypoglycaemia. A group from Korea have evaluated a
hypoglycaemia reduction course following structured inten-
sive diabetes education for adults with type 2 diabetes treated
with insulin or sulfonylureas [48]. They randomised 28 of 56
Educational programmes for minimising hypoglycaemia risk
Educational programmes may promote diabetes self-management while minimising hypoglycaemia risk. 
Programmes aimed at reversing IAH
DTTP Basal and pre-meal bolus insulin separated; intensive SMBG; counting carbohydrates; structured 
written curriculum. In follow-on, taught to calculate insulin doses based on meal carbohydrate values, 
while maintaining blood glucose targets. Improved HbA1c while reducing severe hypoglycaemia.
DTTP-based programmes (e.g. DAFNE) Similar findings to DTTP, plus reduced IAH. The DAFNE study 
also showed reduced psychological distress and improved wellbeing.
Programmes aimed at improving hypoglycaemia awareness 
HypoCOMPaSS Randomised to CGM, insulin pumps or multiple daily injections alone; brief half-day 
education programme focussed on reducing hypoglycaemia episodes. Improved IAH and reduced severe 
hypoglycaemia rates without deterioration in HbA
1c
. 
BGAT Psychoeducational; taught to focus on enhanced awareness of internal cues (physical symptoms, 
cognitive skills, mood changes) and recognise external cues (e.g. timing/dose of previous insulin, food 
intake, exercise) to recognise/anticipate changes in blood glucose. Improved hypoglycaemia detection in 
IAH, less low glucose readings in those without IAH, without deteriorating glycaemic control. 
HAATT Structured education for hypoglycaemia detection; plans for maintaining HAATT principles follow-
ing course. Reduced moderate/severe hypoglycaemia rate without compromising metabolic control. 
HyPOS Exclusively focussed on hypoglycaemia. Improved awareness of hypoglycaemia, no change in 
severe hypoglycaemia rates in the short term, although may improve long-term rates. 
DAFNE-HART Psychoeducational; those with IAH following DAFNE encouraged to seek hypoglycaemia 
cues/consider consequences of hypoglycaemia and IAH using motivational interviewing/cognitive behav-
ioural therapy. Reduced severe hypoglycaemia incidence and improved hypoglycaemia awareness. 
HbA
1c
 was unchanged 12 months post intervention. 
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individuals who had received the initial course to receive ad-
ditional reinforcement teaching on hypoglycaemia. Over
6 months, the intervention group experienced half as many
symptomatic episodes. In contrast, a Chinese study found no
differences in rates of symptomatic hypoglycaemia between
adults with type 2 diabetes starting insulin therapy who were
randomised to receive structured education and their control
group [49]. The X-PERT programme, delivered in the UK,
studied 314 people with type 2 diabetes and randomised them
to either individual appointments with a dietitian (control
group) or a self-management programme administered over
six 2 h visits with a dietitian (intervention group) [50]. There
was a significant reduction in mean HbA1c (0.6%) in addition
to improved body weight, lipid profiles, foot care and overall
satisfaction in the intervention group vs control group [50].
There was, however, no statistically significant difference in
the mean frequency of hypoglycaemia between the interven-
tion and control groups at 4 month follow-up. It appears that
only a small proportion (<20%) were on insulin at baseline.
In light of the rising global costs associated with diabetes
care, recently estimated at a substantial 825 billion US dollars
annually [51], it is relevant to compare the cost-effectiveness
of educational interventions in relation to other approaches,
such as technology. Economic modelling of the DAFNE pro-
gramme indicates greater life expectancy and reduced inci-
dence of diabetes-related complications and this programme
would be considered cost-effective according to the National
Institute for Health and Care Excellence (NICE) criteria [52].
Evidence in type 2 diabetes also suggests that structured edu-
cation, which empowers individuals to self-manage their con-
dition and leads to positive changes in lifestyle, yields added
health benefits at reasonable costs [53].
Conclusions
Despite significant technological advances in insulin therapy
over the last 20 years, hypoglycaemia continues to be a major
barrier to the effective treatment of diabetes, which aims to
prevent the development of diabetes-related complications.
There is reasonable evidence from both RCTs and observa-
tional studies that structured education (defined as insulin self-
management and/or specific training in hypoglycaemia avoid-
ance) leads to reductions in the rates of severe hypoglycaemia
in type 1 diabetes, while improving glycaemic control.
Emerging evidence suggests that individuals with IAH at high
risk of severe hypoglycaemia benefit from specific education-
al interventions. This particularly applies to structured ap-
proaches that target both educational and psychological is-
sues, although further research is needed. No studies in type
2 diabetes have demonstrated that structured education can
lower the risk of severe hypoglycaemia in individuals with
insulin-treated type 2 diabetes. There is an urgent need for
further work, particularly in those at greatest potential risk
(i.e. a long duration of insulin treatment and reduced
hypoglycaemia awareness). In the meantime, structured edu-
cation should be part of routine management for all those with
type 1 diabetes.
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